Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Why cyclooxygenase-2 inhibition plus chemotherapy?

Sweeney CJ. Why cyclooxygenase-2 inhibition plus chemotherapy? Am J Clin Oncol. 2003 Aug; 26(4):S122-5.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.